Convelo Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$12M
- Investors
-
3
Convelo General Information
Description
Developer of stem cell based therapeutics designed to discover medicines for the regenerative capacity of the central nervous system. The company identifies novel drug candidates capable of directly stimulating oligodendrocyte progenitor cells to form new myelin and controls myelination, including defined drug-target, enabling medical researchers to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases.
Contact Information
Website
www.convelotx.comCorporate Office
- 11000 Cedar Avenue
- Cleveland, OH 44106
- United States
Corporate Office
- 11000 Cedar Avenue
- Cleveland, OH 44106
- United States
Convelo Timeline
Convelo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series C) | 14-Nov-2024 | $12M | Completed | Pre-Clinical Trials | ||
| 5. Later Stage VC (Series B) | 08-Dec-2022 | Completed | Clinical Trials - Phase 1 | |||
| 4. Secondary Transaction - Private | 07-Dec-2020 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC (Series A) | 25-Jul-2018 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | $2M | Completed | Startup | |||
| 1. Seed Round | 05-Dec-2017 | $2M | $2M | Completed | Startup |
Convelo Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 10,482,621 | $0.000100 | 6% | $0.75 | $0.75 | 1x | $0.75 | 21.58% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Convelo Patents
Convelo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026112292-A1 | Spirocyclic compounds for use in promoting remyelination | Pending | 20-Nov-2024 | ||
| WO-2026015548-A1 | Cyp51 inhibitors and method of using same | Pending | 08-Jul-2024 | ||
| AU-2024334493-A1 | Tertiary pyridyl amine modulators of cholesterol biosynthesis and their use for promoting remylination | Pending | 28-Aug-2023 | ||
| EP-4770996-A1 | Tertiary pyridyl amine modulators of cholesterol biosynthesis and their use for promoting remylination | Pending | 28-Aug-2023 | ||
| WO-2025049495-A1 | Tertiary pyridyl amine modulators of cholesterol biosynthesis and their use for promoting remylination | Inactive | 28-Aug-2023 | C07D401/14 |
Convelo Signals
Convelo Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| JobsOhio Ventures | Venture Capital | Minority | ||
| Cleveland Convelo Holdings | Corporation | Minority | ||
| Jumpstart Ventures | Venture Capital | Minority |
Convelo FAQs
-
When was Convelo founded?
Convelo was founded in 2016.
-
Where is Convelo headquartered?
Convelo is headquartered in Cleveland, OH.
-
What is the size of Convelo?
Convelo has 11 total employees.
-
What industry is Convelo in?
Convelo’s primary industry is Drug Discovery.
-
Is Convelo a private or public company?
Convelo is a Private company.
-
What is the current valuation of Convelo?
The current valuation of Convelo is .
-
What is Convelo’s current revenue?
The current revenue for Convelo is .
-
How much funding has Convelo raised over time?
Convelo has raised $32.6M.
-
Who are Convelo’s investors?
JobsOhio Ventures, Cleveland Convelo Holdings, and Jumpstart Ventures have invested in Convelo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process